IGF-1 Receptors in Mammalian Longevity: Less is More

  • Martin Holzenberger
Part of the Research and Perspectives in Endocrine Interactions book series (RPEI)

Summary

Recent advances in research into ageing mechanisms have revealed that the cellular receptors InR and DAF-2 control the life span of fruit flies and roundworms, respectively. Comparative studies have identified these structurally and evolutionarily related tyrosine kinase receptors as orthologues of the mammalian insulin receptor (IR) and insulin-like growth factor receptor type 1 (IGF-1R). We investigated whether IGF-1R also regulates life span in mammals, by targeting the gene encoding this receptor in the mouse. Mice with a homozygous null mutation of this gene (IGF-1R−/−) were not viable because of severe growth retardation and developmental immaturity at birth. Heterozygous knockout mice (IGF-1R+/−) were, however, fully viable, and we studied life span and a number of age-related physiological parameters in this model (Holzenberger et al. 2003). Heterozygous knockout mice presented a 50% decrease in the number of IGF-1 receptors in all tissues but were healthy despite this defect. Life span analysis, comparing IGF-1R+/− mice with their wild-type littermates, showed that this mutation significantly increased longevity, by 26%, when both sexes were analysed together. Evaluated separately, IGF-1R+/− females lived 33% longer than wild-type females, whereas male mutants lived 16% longer than wild-type males. Growth and development were normal in long-lived IGF-1R+/− mice. They displayed no dwarfism, had normal energy metabolism and nutrient uptake, and physical activity identical to that of their wild-type control littermates. Moreover, no change was observed in male and female fertility and reproduction. IGF-1R+/− mutants displayed a high level of resistance in vivo to oxidative stress, a widely accepted key determinant of the ageing process. This finding was reproduced in vitro in experiments with mutant embryonic fibroblasts with hydrogen peroxide treatment used to generate oxidative stress. We tried to unravel the molecular mechanisms involved in life span control via IGF signalling by examining the major intracellular pathways involved. We found that levels of Akt and Erk1/2 MAP kinase activation were clearly diminished in cells derived from long-lived mutants. Moreover, the signal transduction molecule p66 Shc (one of the isoforms of Shc, and also a major substrate of IGF-1R), previously shown to control both the cellular response to oxidative stress and life span in mice, also showed a clear lack of activation in IGF-1R+/− cells. This finding provides the first mechanistic evidence for a link between IGF-1R activation and the regulation of stress resistance. Overall, our results strongly suggest a possible role for the IGF-1 receptor as a major regulator of mammalian longevity. There is also circumstantial evidence of a relationship between growth and longevity in humans, but further studies are required to formally identify the human genes determining life span. Recent studies in C. elegans have shown that life span is regulated in a non cell-autonomous fashion, and that the nervous system may play a central role in these processes. Together, these exciting findings open up new avenues of research, including the possibility of extending life span pharmacologically.

Keywords

Hydrogen Peroxide Estrogen Tyrosine Recombination Clarification 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Apfeld J, Kenyon C (1998) Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and lifespan. Cell 95: 199–210PubMedCrossRefGoogle Scholar
  2. Bartke A (2001) Mutations prolong life in flies; implications for aging in mammals. Trends Endocrinol Metab 12: 233–234PubMedCrossRefGoogle Scholar
  3. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth GS (2001) Extending the lifespan of long-lived mice. Nature 414: 412PubMedCrossRefGoogle Scholar
  4. Blüher M, Kahn B, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572–574PubMedCrossRefGoogle Scholar
  5. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384: 33PubMedCrossRefGoogle Scholar
  6. Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D (1998) Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol 121: 19–26PubMedCrossRefGoogle Scholar
  7. Carter CS, Ramsey MM, Sonntag WE (2002) A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. TIGS 18: 295–301CrossRefGoogle Scholar
  8. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, Partridge L (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104–106PubMedCrossRefGoogle Scholar
  9. Clancy DJ, Gems D, Hafen E, Leevers SJ, Partridge L (2002) Dietary restriction in long-lived dwarf flies. Science 296: 319PubMedCrossRefGoogle Scholar
  10. Coschigano KT, Clemmons D, Bellushi LL, Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141: 2608–2613PubMedCrossRefGoogle Scholar
  11. De Meyts, Whittaker J (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1: 769–783CrossRefGoogle Scholar
  12. Dupont J, Karas M, LeRoith D (2000) The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275: 35893–35901PubMedCrossRefGoogle Scholar
  13. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247PubMedCrossRefGoogle Scholar
  14. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98: 6736–6741PubMedCrossRefGoogle Scholar
  15. Gems D, Partridge L (2001) Insulin/IGF signalling and ageing: seeing the bigger picture. Curr Opin Genet Dev 11: 287–292PubMedCrossRefGoogle Scholar
  16. Guarente L, Kenyon C (2000) Genetic pathways that regulate ageing in model organisms. Nature 408: 255–262PubMedCrossRefGoogle Scholar
  17. Holzenberger M, Martin-Crespo RM, Vicent D, Ruiz-Torres A (1991) Decelerated growth and longevity in men. Arch Gerontol Geriat 13: 89–101CrossRefGoogle Scholar
  18. Holzenberger M, Leneuve P, Hamard G, Ducos B, Périn L, Binoux M, Le Bouc Y (2000a) A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 141: 2557–2566PubMedCrossRefGoogle Scholar
  19. Holzenberger M, Lenzner C, Leneuve P, Zaoui R, Hamard G, Vaulont S, Le Bouc Y (2000b) Cremediated germ-line mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res 28: e92PubMedCrossRefGoogle Scholar
  20. Holzenberger M, Hamard G, Zaoui R, Leneuve P, Ducos B, Beccavin C, Périn L, Le Bouc Y (2001) Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology 142: 4469–4478PubMedCrossRefGoogle Scholar
  21. Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, Cervera P, Le Bouc Y (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182–187PubMedCrossRefGoogle Scholar
  22. Honda Y, Honda S (2002) Oxidative stress and life span determination in the nematode Caenorhabditis elegans. Ann NY Acad Sci 959: 466–474PubMedCrossRefGoogle Scholar
  23. Hsin H, Kenyon C (1999) Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399: 362–366PubMedCrossRefGoogle Scholar
  24. Hunter WS, Croson WB, Bartke A, Gentry MV, Meliska CJ (1999) Low body temperature in long-lived Ames dwarf mice at rest and during stress. Physiol Behav 67: 433–437PubMedCrossRefGoogle Scholar
  25. Kenyon C (2001) A conserved regulatory system for aging. Cell 105: 165–168PubMedCrossRefGoogle Scholar
  26. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461–464PubMedCrossRefGoogle Scholar
  27. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G (1997) Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942–946PubMedCrossRefGoogle Scholar
  28. Krzisnik C, Kolacio Z, Battelino T, Brown M, Parks JS and Laron Z (1999) The “Little People” of the island of Krk - revisited. Etiology of hypopituitarism revealed. J Endocrine Genet 1: 9–19Google Scholar
  29. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329–339PubMedCrossRefGoogle Scholar
  30. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR (2002) β-cell specific deletion of the IGF-1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter 13-cell mass. Nat Genet 31: 111–115Google Scholar
  31. Leneuve P, Zaoui R, Monget P, Le Bouc Y, Holzenberger M (2001) Genotyping of Cre-lox mice and detection of tissue-specific recombination by multiplex PCR. Biotechniques 31: 1156–1162PubMedGoogle Scholar
  32. Liu JL, Grinberg A, Westphal H, Sauer B, Accili D, Karas M, LeRoith D (1998) Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol 12: 1452–1462PubMedCrossRefGoogle Scholar
  33. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75: 59–72PubMedGoogle Scholar
  34. Lupu L, Terwilliger JD, Lee K, Segre GU, Efstratiadis A (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229: 141–162PubMedCrossRefGoogle Scholar
  35. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG (1999) The p66’ adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309–313PubMedCrossRefGoogle Scholar
  36. Samaras TT, Storms LH (1992) Impact of height and weight on life span. Bull World Health Org 70: 259–267PubMedGoogle Scholar
  37. Smith GS, Walford RL, Mickey MR (1973) Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst 50: 1195–1213PubMedGoogle Scholar
  38. Stevens LC, Little CC (1954) Spontaneous testicular teratomas in an inbred strain of mice. Proc Natl Acad Sci USA 40: 1080–1087PubMedCrossRefGoogle Scholar
  39. Sun J, Tower J (1999) FLP recombinase-mediated induction of Cu/Zn-superoxide dismutase transgene expression can extend the life span of adult Drosophila melanogaster flies. Mol Cell Biol 19: 216–228PubMedGoogle Scholar
  40. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292: 107–110PubMedCrossRefGoogle Scholar
  41. Tissenbaum HA, Ruvkun G (1998) An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148: 703–717PubMedGoogle Scholar
  42. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF (1999) Irs-2 coordinates IGF-1 receptor-mediated ß-cell development and peripheral insulin signalling. Nat Genet 23: 32–39PubMedGoogle Scholar
  43. Wolkow CA (2002) Life span: getting the signal from the nervous system. Trends Neurosci 25: 212–216PubMedCrossRefGoogle Scholar
  44. Wolkow CA, Kimura KD, Lee MS, Ruvkun G (2000) Regulation of C. elegans life-span by insulin-like signaling in the nervous system. Science 290: 147–150PubMedCrossRefGoogle Scholar
  45. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96: 7327–7329CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Martin Holzenberger

There are no affiliations available

Personalised recommendations